Biotechnology FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis April 20, 2022
Biotechnology Alkermes Commences Arbitration Related to License Agreements with Janssen Pharmaceutica April 19, 2022
Biotechnology Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022 April 19, 2022
Biotechnology Amicus Announces Issuance of New U.S. Composition of Matter Patent for Galafold® (migalastat), Strengthening Patent Protection Through 2038 April 19, 2022
Search
Biotechnology
